Quarterly report pursuant to Section 13 or 15(d)

Description of Business, Liquidity and Capital Resources (Details)

v3.21.1
Description of Business, Liquidity and Capital Resources (Details) - USD ($)
3 Months Ended
Apr. 01, 2021
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Description of Business, Liquidity and Capital Resources (Textual)        
Net proceeds of secured convertible notes   $ 7,500,000    
Cash in operations   $ (1,373,818) $ (3,913,769)  
Cost reduction initiatives, description   cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $3.0 million to $4.0 million.    
Loss from operations   $ (3,506,003) $ (4,878,702)  
Cash   15,426,759   $ 17,840,640
Installment Amount   $ 4,400,000    
Subsequent Event [Member] | Viridian Sciences Inc [Member]        
Description of Business, Liquidity and Capital Resources (Textual)        
Value of business acquired $ 6,000,000